Fumihito Suzuki

Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis.

Sae Ochi, Toshihiro Nanki, Kazuki Takada et al. · PubMed · 2005 · 69 citations

Pharmacy, Dermatology, Pharmacotherapy +10

Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice

Fumihito Suzuki, Toshihiro Nanki, Toshio Imai et al. · The Journal of Immunology · 2005 · 61 citations · Full text

Medicine, Immunology, Pathology +17

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial

Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani et al. · Arthritis Research & Therapy · 2017 · 54 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo

Naho Ohyanagi, Miwako Ishido, Fumihito Suzuki et al. · Arthritis & Rheumatism · 2009 · 30 citations

Life Sciences, Immunology, Pathology +16

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity

Fumihito Suzuki, Tetsuo Kubota, Yasunari Miyazaki et al. · Arthritis Research & Therapy · 2012 · 29 citations · Full text

Veterinary Medicine, Immunology, Pathology +14